As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?
By Maggie Fick and Diana Novak Jones LONDON (Reuters) -In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug Wegovy, one name remains conspicuously absent: Hims & Hers. The high-profile telehealth company continues to sell compounded versions of Wegovy at lower prices, testing the limits of …
As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims? Read More »








